Global Varicella Vaccine Market Research Report 2023(Status and Outlook)

Global Varicella Vaccine Market Research Report 2023(Status and Outlook)



Report Overview

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin

Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.

Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.

In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.

The Global Varicella Vaccine Market Size was estimated at USD 3872.00 million in 2022 and is projected to reach USD 6550.38 million by 2029, exhibiting a CAGR of 7.80% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Varicella Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Varicella Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Varicella Vaccine market in any manner.

Global Varicella Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

GSK

Shanghai Institute

BCHT

Changsheng

Keygen

Green Cross

Biken

Market Segmentation (by Type)

Injection

Freeze-Dried Powder

Market Segmentation (by Application)

Hospital

Retail Pharmacies

Long-term Care Facilities

Mail-order Pharmacies

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Varicella Vaccine Market

Overview of the regional outlook of the Varicella Vaccine Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Varicella Vaccine
1.2 Key Market Segments
1.2.1 Varicella Vaccine Segment by Type
1.2.2 Varicella Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Varicella Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Varicella Vaccine Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Varicella Vaccine Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Varicella Vaccine Market Competitive Landscape
3.1 Global Varicella Vaccine Sales by Manufacturers (2018-2023)
3.2 Global Varicella Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.3 Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Varicella Vaccine Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Varicella Vaccine Sales Sites, Area Served, Product Type
3.6 Varicella Vaccine Market Competitive Situation and Trends
3.6.1 Varicella Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Varicella Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Varicella Vaccine Industry Chain Analysis
4.1 Varicella Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Varicella Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Varicella Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Varicella Vaccine Sales Market Share by Type (2018-2023)
6.3 Global Varicella Vaccine Market Size Market Share by Type (2018-2023)
6.4 Global Varicella Vaccine Price by Type (2018-2023)
7 Varicella Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Varicella Vaccine Market Sales by Application (2018-2023)
7.3 Global Varicella Vaccine Market Size (M USD) by Application (2018-2023)
7.4 Global Varicella Vaccine Sales Growth Rate by Application (2018-2023)
8 Varicella Vaccine Market Segmentation by Region
8.1 Global Varicella Vaccine Sales by Region
8.1.1 Global Varicella Vaccine Sales by Region
8.1.2 Global Varicella Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Varicella Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Varicella Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Varicella Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Varicella Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Varicella Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Varicella Vaccine Basic Information
9.1.2 Merck Varicella Vaccine Product Overview
9.1.3 Merck Varicella Vaccine Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Varicella Vaccine SWOT Analysis
9.1.6 Merck Recent Developments
9.2 GSK
9.2.1 GSK Varicella Vaccine Basic Information
9.2.2 GSK Varicella Vaccine Product Overview
9.2.3 GSK Varicella Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Varicella Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Shanghai Institute
9.3.1 Shanghai Institute Varicella Vaccine Basic Information
9.3.2 Shanghai Institute Varicella Vaccine Product Overview
9.3.3 Shanghai Institute Varicella Vaccine Product Market Performance
9.3.4 Shanghai Institute Business Overview
9.3.5 Shanghai Institute Varicella Vaccine SWOT Analysis
9.3.6 Shanghai Institute Recent Developments
9.4 BCHT
9.4.1 BCHT Varicella Vaccine Basic Information
9.4.2 BCHT Varicella Vaccine Product Overview
9.4.3 BCHT Varicella Vaccine Product Market Performance
9.4.4 BCHT Business Overview
9.4.5 BCHT Varicella Vaccine SWOT Analysis
9.4.6 BCHT Recent Developments
9.5 Changsheng
9.5.1 Changsheng Varicella Vaccine Basic Information
9.5.2 Changsheng Varicella Vaccine Product Overview
9.5.3 Changsheng Varicella Vaccine Product Market Performance
9.5.4 Changsheng Business Overview
9.5.5 Changsheng Varicella Vaccine SWOT Analysis
9.5.6 Changsheng Recent Developments
9.6 Keygen
9.6.1 Keygen Varicella Vaccine Basic Information
9.6.2 Keygen Varicella Vaccine Product Overview
9.6.3 Keygen Varicella Vaccine Product Market Performance
9.6.4 Keygen Business Overview
9.6.5 Keygen Recent Developments
9.7 Green Cross
9.7.1 Green Cross Varicella Vaccine Basic Information
9.7.2 Green Cross Varicella Vaccine Product Overview
9.7.3 Green Cross Varicella Vaccine Product Market Performance
9.7.4 Green Cross Business Overview
9.7.5 Green Cross Recent Developments
9.8 Biken
9.8.1 Biken Varicella Vaccine Basic Information
9.8.2 Biken Varicella Vaccine Product Overview
9.8.3 Biken Varicella Vaccine Product Market Performance
9.8.4 Biken Business Overview
9.8.5 Biken Recent Developments
10 Varicella Vaccine Market Forecast by Region
10.1 Global Varicella Vaccine Market Size Forecast
10.2 Global Varicella Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Varicella Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Varicella Vaccine Market Size Forecast by Region
10.2.4 South America Varicella Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Varicella Vaccine by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Varicella Vaccine Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Varicella Vaccine by Type (2024-2029)
11.1.2 Global Varicella Vaccine Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Varicella Vaccine by Type (2024-2029)
11.2 Global Varicella Vaccine Market Forecast by Application (2024-2029)
11.2.1 Global Varicella Vaccine Sales (K MT) Forecast by Application
11.2.2 Global Varicella Vaccine Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings